drugset / Trial / NCT05362851
Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee
RandomizedParallel-groupDouble-blindTreatment
Summary
A Multi-center, Double-blinded, Randomized, Active-controlled, Parallel Design, phase 3 Clinical Trial to Evaluate the Efficacy and Safety of YYC301 in Patients with Osteoarthritis of the Knee Joint
Timeline
- Start
- 2021-11-11
- Primary completion
- 2023-01-31
- Completion
- 2023-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 200 mg | — |
| Subject | Tramadol | Other / unclassified | 37.5 mg | — |
| Subject | Tramadol | Other / unclassified | 75 mg | — |
| Subject | Tramadol | Other / unclassified | 150 mg | — |